Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy - PubMed (original) (raw)
Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy
H P Hammes et al. Proc Natl Acad Sci U S A. 1991.
Erratum in
- Proc Natl Acad Sci U S A 1992 Oct 1;89(19):9364
Abstract
Retinal capillary closure induced by hyperglycemia is the principal pathophysiologic abnormality underlying diabetic retinopathy, but the mechanisms by which this induction occurs are not clear. Treatment of diabetic rats for 26 weeks with aminoguanidine, an inhibitor of advanced glycosylation product formation, prevented a 2.6-fold accumulation of these products at branching sites of precapillary arterioles where abnormal periodic acid/Schiff reagent-positive deposits also occurred. Aminoguanidine treatment completely prevented abnormal endothelial cell proliferation and significantly diminished pericyte dropout. After 75 weeks, untreated diabetic animals developed an 18.6-fold increase in the number of acellular capillaries and formed capillary microaneurysms, characteristic pathologic features of background diabetic retinopathy. In contrast, aminoguanidine-treated diabetic animals had only a 3.6-fold increase in acellular capillaries and no microaneurysms. These findings indicate that advanced glycosylation product accumulation contributes to the development of diabetic retinopathy and suggest that aminoguanidine may have future therapeutic use in this disorder.
Similar articles
- Aminoguanidine inhibits the development of accelerated diabetic retinopathy in the spontaneous hypertensive rat.
Hammes HP, Brownlee M, Edelstein D, Saleck M, Martin S, Federlin K. Hammes HP, et al. Diabetologia. 1994 Jan;37(1):32-5. doi: 10.1007/BF00428774. Diabetologia. 1994. PMID: 8150227 - Secondary intervention with aminoguanidine retards the progression of diabetic retinopathy in the rat model.
Hammes HP, Strödter D, Weiss A, Bretzel RG, Federlin K, Brownlee M. Hammes HP, et al. Diabetologia. 1995 Jun;38(6):656-60. doi: 10.1007/BF00401835. Diabetologia. 1995. PMID: 7672485 - Islet transplantation inhibits diabetic retinopathy in the sucrose-fed diabetic Cohen rat.
Hammes HP, Klinzing I, Wiegand S, Bretzel RG, Cohen AM, Federlin K. Hammes HP, et al. Invest Ophthalmol Vis Sci. 1993 May;34(6):2092-6. Invest Ophthalmol Vis Sci. 1993. PMID: 8491559 - Glycation products and the pathogenesis of diabetic complications.
Brownlee M. Brownlee M. Diabetes Care. 1992 Dec;15(12):1835-43. doi: 10.2337/diacare.15.12.1835. Diabetes Care. 1992. PMID: 1464241 Review. - [Outlook for the future in the treatment of diabetic retinopathy].
Vialettes B, Silvestre-Aillaud P, Atlan-Gepner C. Vialettes B, et al. Diabete Metab. 1994;20(2 Pt 2):229-34. Diabete Metab. 1994. PMID: 7528151 Review. French.
Cited by
- Advanced Glycation End Products Upregulate CD40 in Human Retinal Endothelial and Müller Cells: Relevance to Diabetic Retinopathy.
Portillo JC, Pfaff A, Vos S, Weng M, Nagaraj RH, Subauste CS. Portillo JC, et al. Cells. 2024 Feb 29;13(5):429. doi: 10.3390/cells13050429. Cells. 2024. PMID: 38474393 Free PMC article. - Oxidative Stress and Its Regulation in Diabetic Retinopathy.
Haydinger CD, Oliver GF, Ashander LM, Smith JR. Haydinger CD, et al. Antioxidants (Basel). 2023 Aug 21;12(8):1649. doi: 10.3390/antiox12081649. Antioxidants (Basel). 2023. PMID: 37627644 Free PMC article. Review. - Pericyte Loss in Diseases.
Li P, Fan H. Li P, et al. Cells. 2023 Jul 26;12(15):1931. doi: 10.3390/cells12151931. Cells. 2023. PMID: 37566011 Free PMC article. Review. - The effect of GLP-1 receptor agonist lixisenatide on experimental diabetic retinopathy.
Oezer K, Kolibabka M, Gassenhuber J, Dietrich N, Fleming T, Schlotterer A, Morcos M, Wohlfart P, Hammes HP. Oezer K, et al. Acta Diabetol. 2023 Nov;60(11):1551-1565. doi: 10.1007/s00592-023-02135-7. Epub 2023 Jul 9. Acta Diabetol. 2023. PMID: 37423944 Free PMC article.
References
- Proc Natl Acad Sci U S A. 1989 Jul;86(13):5141-5 - PubMed
- Diabetes. 1989 Oct;38(10):1203-6 - PubMed
- Science. 1988 Jun 10;240(4858):1546-8 - PubMed
- JAMA. 1988 Nov 18;260(19):2864-71 - PubMed
- J Biol Chem. 1988 Mar 25;263(9):4302-8 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical